Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Veracyte reported $92.92M in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
Agenus AGEN:US USD 77.24M 10.84M
Agilent A:US USD 1.33B 4M
Anika Therapeutics ANIK:US USD 35.4M 10.89M
Arrowhead Research ARWR:US USD 98.1M 6.58M
Bruker BRKR:US USD 562.6M 14.8M
Exact Sciences EXAS:US USD 679.54M 7.66M
Heron Therapeutics HRTX:US USD 62.68M 12.3M
Illumina ILMN:US USD 1.15B 59M
Immunogen IMGN:US USD 92.26M 8.46M
Intrexon XON:US USD 25.33M 1.77M
Karyopharm Therapeutics KPTI:US USD 69.6M 2.15M
Laboratory Of America LH:US USD 3.44B 146.6M
Ligand Pharmaceuticals LGND:US USD 29.77M 14.9M
Myriad Genetics MYGN:US USD 233.4M 3.4M
Rigel Pharmaceuticals RIGL:US USD 38.8M 10.4M
Roche Holding ROG:VX CHF 25.06B 4.31B
Sangamo BioSciences SGMO:US USD 139.92M 57.3M
Siemens SIE:GR EUR 17.19B 1.35B
Sonic Healthcare SHL:AU AUD 3.5B 132.13M
Thermo Fisher Scientific TMO:US USD 9.15B 442M
Veracyte VCYT:US USD 92.92M 7.2M
Waters WAT:US USD 510.51M 61.72M